...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Dec 2016 article - apologies if already posted. Didn't see it in "Link Library"
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Imtesty,

You are correct. That one was missing from the link library. I added all available posters (that contain the abstract and more) from the Zenith website to the link library. I also added the abstract from the AACR 2015 meeting that you pointed out in your previous message. Thanks for helping keep this site up to date!

BearDownAZ

P.S. I will do the same over the next couple of days for the Resverlogix Agoracom Hub. 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply